Ronan O'Cualain

Bridging Discovery & Clinical Translation: InoKey™ for Biomarker-Driven Drug Development - Inoviv InoKey™ represents a significant advancement in proteomics, offering a disease-agnostic platform that empowers researchers worldwide. By bridging the translational biomarker gap, it facilitates the de...

Advancing #proteomics for #clinical impact. Inoviv’s latest blog explores the development and validation of a COVID-19 #proteomic assay, enabling precision in disease staging and treatment escalation.

Read more - inoviv.com/blog-bridgin...

#biopharma #biomarkers #massspec #precisionmedicine

11.02.2025 17:26 — 👍 3    🔁 1    💬 0    📌 0

@ben-gonzales.bsky.social

17.01.2025 10:49 — 👍 1    🔁 0    💬 0    📌 0

image of comparison between different types of mass spectrometer

I made a breakdown of commonly used instruments in proteomics for an upcoming talk, which ones have I missed? @proteomics.bsky.social @proteomic.bsky.social

28.11.2024 14:49 — 👍 2    🔁 0    💬 0    📌 0

Lol, nope not early career! Thanks for the add

25.11.2024 11:26 — 👍 1    🔁 0    💬 1    📌 0

I'd like to be added please

25.11.2024 07:37 — 👍 1    🔁 0    💬 1    📌 0

bsky.app/starter-pack...

12.11.2024 14:36 — 👍 5    🔁 3    💬 0    📌 0

#TeamMassSpec recent newcomers you'll want to follow:
@jespervolsen.bsky.social @kmechtler.bsky.social @vadim-demichev.bsky.social
@nesvilab.bsky.social @nlkproteomics.bsky.social

18.11.2024 15:25 — 👍 16    🔁 7    💬 0    📌 0